BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38246986)

  • 1. Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study.
    Xie J; Wang X; Wang X; Li J; Jie Y; Hao Y; Gu J
    Glob Health Res Policy; 2024 Jan; 9(1):5. PubMed ID: 38246986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.
    Zheng Y; Wu J; Ding C; Xu K; Yang S; Li L
    Virol J; 2020 Aug; 17(1):132. PubMed ID: 32859216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
    Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
    BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink.
    Ferreira G; Stuurman AL; Horsmans Y; Cattaert T; Verstraeten T; Feng Y; Rosillon D; Guignard A
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):101-109. PubMed ID: 31651649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
    Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019.
    Xie J; Lin X; Fan X; Wang X; Pan D; Li J; Hao Y; Jie Y; Zhang L; Gu J
    J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38713342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.
    Nguyen VT; Law MG; Dore GJ
    Liver Int; 2008 Apr; 28(4):525-31. PubMed ID: 18266635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China.
    Xiao J; Lin H; Liu T; Zeng W; Li X; Shao X; Tan Q; Xu Y; Xu X; Zheng H; Ma W
    Int J Environ Res Public Health; 2015 Nov; 12(11):14055-67. PubMed ID: 26540065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
    Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
    Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
    Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk analysis for hepatocellular carcinoma in patients with chronic hepatitis B-associated cirrhosis complicated by type 2 diabetes mellitus: a 5-year prospective cohort study].
    Tang C; Hu C; Zhou Y; Song Y; Li M; Liao M; Sun J; Zhong C; Zhou L; Lin Z; Zhou Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):313-318. PubMed ID: 33849820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.
    Li X; Xu H; Gao P
    Med Sci Monit; 2018 Sep; 24():6729-6734. PubMed ID: 30245503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current and future burden of hepatitis B in Switzerland: a modelling study.
    Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
    Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study.
    Lin S; Zhang K; Zhang J; Wang M; Velani B; Zhu Y
    Liver Int; 2019 May; 39(5):854-860. PubMed ID: 30753752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.